Trevi Therapeutics shifts to late-stage biotech with Haduvio for IPF chronic cough. Click here to read my latest analysis of ...
NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Once technology is validated and network effects begin to take hold, the next question investors should ask is simple: how efficiently can this ...
AGOURA HILLS, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“Oncotelic” or the “Company”), a clinical ...
EMERYVILLE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...
WEST HOLLYWOOD, Calif. and TEL AVIV, Israel, Oct. 29, 2025 /PRNewswire/ -- VisionWave Holdings, Inc.(Nasdaq: VWAV), a defense-technology company redefining autonomous mission systems, today announced ...
NEW YORK, NY / ACCESS Newswire / December 24, 2025 / Once technology is validated and network effects begin to take hold, the next question investors should ask is simple: how efficiently can this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results